Filing Details
- Accession Number:
- 0001209191-14-078388
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-12-30 16:56:15
- Reporting Period:
- 2014-12-26
- Filing Date:
- 2014-12-30
- Accepted Time:
- 2014-12-30 16:56:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1513818 | Versartis Inc. | VSAR | Pharmaceutical Preparations (2834) | 244106690 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1601948 | L Jeffrey Cleland | C/O Versartis, Inc. 4200 Bohannon Drive, Suite 250 Menlo Park CA 94025 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-12-26 | 32,160 | $0.00 | 129,432 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2014-12-29 | 4,000 | $22.11 | 125,432 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2014-12-26 | 75,041 | $0.00 | 75,041 | $22.24 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 75,041 | 2024-12-25 | No | 4 | A | Direct |
Footnotes
- Represents the grant of Restricted Stock Units that vest as follows: 25% of the shares subject to the Restricted Stock Units vest on each of December 26, 2015, December 26, 2016, December 26, 2017 and December 26, 2018.
- Shares sold pursuant to a 10b5-1 trading plan.
- The shares were sold at prices ranging from $21.79 to $22.56. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- 1/48th of the shares subject to the option become exercisable monthly measured from the date of grant.
Billionaire Hedge Funds
